The metabolic improvement effect of blueberries has long been recognized, although its precise mechanism(s) remains obscure. Here, we show that phenolic blueberry extract (BE) treatment improved diet-and genetically induced metabolic syndromes, which were linked to increased energy expenditure in brown adipose tissue (BAT) and improved lipid metabolism in the liver via pathways involving the bile acid (BA) receptors TGR5 and FXR. These observations were strongly correlated with the regulation of BAs (e.g., a decrease in the FXR inhibitors TaMCA and TbMCA) and the gut microbiota (GM) (e.g., an expansion of Bifidobacteria and Lactobacillus), because antibiotic treatment completely blunted the regulation of the GM and BAs and the metabolic effects of BE. We also observed similar results in db/db mice. Furthermore, treating mouse primary cells derived from the liver and BAT with the combinations of BAs mimicking the in vivo alterations upon BE treatment mirrored the in vivo observations in mice.
HIGHLIGHTS
Blueberry extract (BE) treatment improved obesity-related metabolic syndromes in mice BE treatment regulated the plasma bile acid (BA) pool through gut microbiota BE treatment decreased serum-conjugated BA contents and increased free secondary BAs BE treatment activated BA receptors TGR5 and FXR in brown adipose tissue and liver
INTRODUCTION
The antimetabolic disease function of plant polyphenols (PPs) has long been noted by researchers studying the ''health secrets'' of people following Mediterranean diet, which contains abundant PPs (Kastorini et al., 2011) . Numerous animal and human studies have demonstrated that, although controversial, PPs from fruits, vegetables, and wines can improve diet-induced obesity and its related metabolic syndromes, including inflammation and insulin resistance (IR) Tresserra-Rimbau et al., 2015) . Certain mechanisms underlying these phenotypes have been studied, such as the inhibition of a-glucosidase, enhancement of pancreatic b-cell function, and regulation of liver function (Hanhineva et al., 2010) . However, the reasons for these effects are unclear, as most natural PPs cannot be absorbed directly by mammals, and the plasma concentration of natural PPs or their metabolites is low, making it difficult to fulfill their physiological function (Kay et al., 2017) .
Recently, the regulation of the gut microbiota (GM) by PPs has received more attention for its potential to improve metabolism. The GM of mammals has fundamental impacts on the host's health in many aspects, such as immunity, psychology, behavior and, especially, energy metabolism (Turnbaugh et al., 2006; Bä ckhed et al., 2004) . The GM plays a significant role in regulating the body weight (BW) of hosts (Ridaura et al., 2013) . Metabolites of the GM are important in regulating the host's metabolism, and, among others, bile acids (BAs) play a key role (Swann et al., 2011) . BAs are synthesized from cholesterol and conjugated to taurine (mouse) or glycine (human) in the liver before being released into the intestine, where they meet microbes. The GM can convert conjugated primary BAs to free BAs via bile salt hydrolase (BSH) and then further to secondary BAs through dehydroxylation and dehydrogenation (Just et al., 2018) . BAs can modulate energy homeostasis through G protein-coupled bile acid receptor 1 (GPBAR1, also known as TGR5) and farnesoid X receptor (FXR, also known as BAR). Supplementation with cholic acid (CA) prevented diet-induced obesity and its related metabolic syndromes in mice via the activation of TGR5 (Watanabe et al., 2006) .
Blueberries (Vaccinium spp.) are rich in PPs (mainly anthocyanins) and known for their antioxidant and cardiovascular protective function (Neto, 2010) . It has been shown that blueberries (or their phenolic extract) were able to ameliorate high-fat diet (HFD)-induced obesity and related metabolic syndromes such as hyperglycemia and IR and to regulate the GM composition (Stull et al., 2010; Defuria et al., 2009) . However, although a correlation between the regulation of the GM and an improvement in metabolism has been observed, neither has the causal link of this relationship nor has the mechanism of this connection been studied yet (Lee et al., 2018) . To investigate the correlation between blueberry PPs, the GM, and metabolism, we performed four independent experiments (three mouse studies and one in vitro study, more details seen in Transparent Methods-Animals and Cell Separation and Culture) employing both mouse and mouse primary cells. The results of this study have implications for understanding the mechanism(s) of the effects of dietary PPs on health and the relationship between the GM and host metabolism.
RESULTS

Blueberry Extract Alleviates Obesity and Liver Steatosis in Diet-Induced Obese Mice
We obtained 2.81 G 0.23 g extract, including 79.62% phenolic compounds, from 100 g fresh blueberry fruit. The hexosides of delphinidin, malvidin, petunidin, cyanidin, myricetin, and quercetin as well as 5-caffeoylquinic acid, vanillic acid, and proanthocyanidins were identified as the most abundant components of the blueberry extract (BE) ( Table S1 ).
For mouse study 1-and 3-week old C57BL/6 male mice were randomly assigned to four groups after adapting for 1 week as follows: (1) a CHOW1 group fed a standard chow diet (3.85 kcal/g, 10% energy from fat), (2) an HFD1 group fed an HFD (4.73 kcal/g, 60% energy from fat), (3) a CBE group (5 gL À1 BE in drinking water) fed a standard chow diet, and (4) a BE1 group (0.5% (m/v) BE in drinking water) fed an HFD. BE treatment significantly reduced diet-induced weight gain from the sixth week of the study until the end of the study, and these findings were not related to energy intake or excretion (Figures 1A, 1B, and 1D) . Moreover, the water consumption was also not influenced by BE treatment ( Figure 1C ). BE-treated mice had reduced body fat, especially in the inguinal white adipose tissue (iWAT), epididymal white adipose tissue (eWAT), and liver (Figures 1E, 1K, 1L, 2F, and 2G) . Liver steatosis and damage induced by an HFD were significantly ameliorated through BE administration, as indicated by decreased hepatic and plasma concentrations of triacylglycerol (TG) ( Figure 1F ) and a reduction in plasma lactate dehydrogenase, alanine transaminase, and aspartate aminotransferase content ( Figure 1G ). BE-treated mice showed an increased energy expenditure ( Figure 1H ), which was not related to physical activity ( Figure 1I ); consistent with this, the core body temperature of BE-treated mice was higher than that of the vehicle-treated HFD-fed mice ( Figure 1J ). Notably, BE treatment had no significant influence on the metabolism of mice fed a chow diet, as shown by parameters such as BW, tissue weight, fat deposition, and plasma biochemical parameters compared with those of chow-fed control mice ( Figure 1 ). Taken together, these results showed that BE administration reduced HFD-induced weight gain and adiposity (partially) by increasing energy expenditure and thermogenesis.
BE Treatment Ameliorates Increased Intestinal Permeability and Systemic Inflammation
Triggered by an HFD and Improves Glucose Metabolism BE treatment alleviated the increased permeability of the colon and distal ileum triggered by an HFD, as indicated by the increased MUC2 levels in the colon and increased mRNA expression of occludin and tight junction protein 1 (TJP1, also known as ZO-1) both in the ileum and colon compared with their expression in mice in the HFD1 group (Figures 2A and 2B ), which was accompanied by a reduction in the mRNA levels of genes related to inflammation, including toll-like receptor 4 (TLR4), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-a) ( Figure 2C ). We also found an improvement in inflammation in white adipose tissue (WAT) and the liver in BE-treated mice, as indicated by the reduced mRNA expression of TLR4, IL-6, and TNF-a and the decreased adipocyte size in the WAT (Figures 2C, 2F and 2G) . Consistent with these results, the plasma concentrations of lipopolysaccharides (LPS), IL-6, and TNF-a were also decreased in BE-treated mice compared with those in vehicle-treated HFD-fed mice ( Figure 2D ).
Glucose metabolism is closely related to systemic inflammation (Gregor and Hotamisligil, 2011) . As expected, BE-treated mice showed profoundly improved glucose intolerance and insulin sensitivity (Figure 2D) . Notably, leptin, a key modulator of energy homeostasis that is usually irregularly high in obese individuals (Friedman and Halaas, 1998) , was lower in the plasma of mice in the BE1 group than in mice in the HFD1 group, and, consistent with this, BE-treated mice showed reduced mRNA expression of CCAAT enhancer-binding proteins b and s (CEBPb and CEBPs) in the iWAT ( Figure 2E ). Similar to the previous observations, systemic inflammation and glucose metabolism in BE-treated chow-fed mice resembled those of vehicle-treated chow-fed mice. Collectively, these results showed that BE administration enhanced the expression of genes related with intestinal barrier integrity, decreased systemic inflammation, and improved glucose metabolism. BE Improves the GM Disturbed by HFD Based on the above results, we concluded that BE administration had a minimal influence on the metabolism of mice fed a chow diet; therefore, we excluded the mice in the CBE group in the following analysis and experiments. Fourteen weeks of treatment with an HFD decreased the richness of the GM and resulted in an abnormal Bacteroidetes to Fimicutes ratio in the HFD1 mice, which were completely restored through BE administration (Figures 3A and 3E) . Intergroup analysis based on the unweighted UniFrac distance showed that BE-treated mice were more similar to mice fed a chow diet ( Figure 3D ) than vehicle-treated HFD-fed mice. Principal coordinate analysis based on the unweighted UniFrac distance also revealed that BE-treated mice were clustered apart from vehicle-treated HFD-fed mice and partially overlapped with mice fed a chow diet ( Figure 3D ).
We employed the linear discriminant analysis effect size (LEfSe) approach to determine the bacterial taxa notably influenced by BE treatment. Consistent with the above results, taxa belonging to the phyla Bacteroidetes and Firmicutes, such as Ruminococcaceae and Bacteroidaceae, were the main features discriminating the GM of BE-treated mice from that of vehicle-treated HFD-fed mice ( Figure 3C ). In addition, the expansion of Akkermansia and Bifidobacterium along with a significant decrease in the Desulfovibrio and Bilophila genera was observed in mice in the BE1 group ( Figure 3C ). Moreover, the abundance of the significant taxa identified through LEfSe analysis was considerably high, as determined through sequencing and qPCR (Figures 3B and 3C) . Collectively, these results demonstrated a substantial alteration and improvement in the GM through BE administration.
BE Changes the Plasma Bile Acid Pool, Promotes the Activation of BAT and the Browning of WAT, and Improves Lipid Metabolism in the Liver and Adipose Tissue As BA metabolism is closely connected with the GM, and they are important regulators of energy homeostasis (Swann et al., 2011) , we sought to determine the influence of BE administration on the BA pool and metabolism. BE administration substantially decreased the augmented plasma BA size induced by an HFD, and conjugated BAs, including tauro-a-muricholic acid (TaMCA), TbMCA, and taurocholic acid (TCA), were the most reduced BAs, among others ( Figure 3F ). Among other highly abundant BAs, lithocholic acid (LCA) and chenodeoxycholic acid (CDCA) were increased; CA, deoxycholic acid (DCA), ursodeoxycholic acid, and tauroursodeoxycholic acid (TUDCA) were not influenced; and hyodeoxycholic acid (HDCA) and tauro-HDCA were decreased in BE-treated mice compared with their levels in mice in the HFD1 group (Figure 3F) . Furthermore, the ratios of primary to secondary as well as conjugated to unconjugated BAs were decreased following BE treatment ( Figure 3F ). The Bifidobacterium and Bacteroides genera, known to produce BSH (Gerard, 2013) , were strongly positively correlated with some unconjugated BAs (e.g., LCA and CA) in the plasma and negatively related to taurine-conjugated BAs including TaMCA, TbMCA, and TCA ( Figure S1C ). The fecal BA level was slightly (p = 0.27) increased, whereas the mRNA expression of ileal bile acid transporter (IBAT, also known as SLC10A2 and ABST) was not influenced by BE treatment ( Figure 3F ), suggesting that the increase in secondary BAs may contribute to the reduced intestinal reabsorption of BAs (Sayin et al., 2013) . Collectively, these results showed that BE administration altered the plasma BA pool and the GM and that there was a strong correlation between the alteration of BA pool and GM.
FXR, an important nuclear BA receptor, controls the expression of various genes related to lipid metabolism, such as sterol-regulatory element binding proteins-1c (SREBP-1c) and carbohydrate-responsive element-binding protein (ChREBP), in the liver (Molinaro et al., 2018) . As BE administration sharply decreased the plasma levels of TaMCA and TbMCA, FXR antagonists (Sayin et al., 2013) , we assessed the influence of their reduced levels on FXR-dependent lipid metabolism. As expected, both the mRNA and protein levels of FXRa and small heterodimer partner (SHP) were significantly elevated, along with the suppression of SREBP-1c and ChREBP, in BE-treated mice compared with those in mice in the HFD1 group ( Figures 3G and 3H ). The mRNA expression levels of genes downstream of SREBP-1c and ChREBP, For all figures, *p < 0.05 and **p < 0.01 for BE1 versus HFD1, # p < 0.05 and ## p < 0.01 for CHOW1 versus HFD1 and different letters indicate a significant difference between columns, p < 0.05.
including proliferator-activated receptor g1 (PPARg1), PPARg2, fatty acid translocase (CD36), fatty acid synthase (FAS), glycerol-3-phosphate acyltransferase (GPAT), and fatty acid-binding protein 4 (FABP4), were all decreased in the livers of BE-treated mice compared with those of vehicle-treated HFD-fed mice (Figure 3G) . Notably, there were strong correlations between the mRNA expression levels of FXRa, SHP, SREBP-1c, ChREBP, FAS, and CD36 ( Figure 3G ). In contrast, the mRNA levels of proteins related to lipolysis, including autophagy-related 4B cysteine peptidase (ATG4b), autophagy-related protein 5 (ATG5), ATG7, carnitine palmitoyltransferase (CPT-I), PPARa, and acetyl-coenzyme A synthetase (ACS), were increased in the livers of BE-treated mice compared with their levels in mice in the HFD1 group ( Figure 3G ). The expression of proteins related to lipid metabolism in WAT and brown adipose tissue (BAT) mirrored the results in the liver, except that FXRa and SHP were not influenced by BE ( Figures S1A and 1B) . Moreover, BE treatment reduced the mRNA expression of cytochrome P450 7A1 (CYP7A1), the key protein controlling BA synthesis, in the liver ( Figure 3F ), which was consistent with the reduced plasma BA pool size. We then sought to determine the effect of BE on the activation of TGR5 in BAT. BE-treated mice showed elevated levels of the membrane BA receptor TGR5 and its downstream gene, deiodinase 2 (D2), in BAT ( Figures 4A and 4D ). Consistent with this, both the mRNA and protein expression of genes related to nonshivering thermogenesis (NST), including uncoupling protein-1 (UCP1), PR domain-containing 16 (PRDM16), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a), were increased in the BAT of BE-treated mice compared with their expression in vehicle-treated HFD-fed mice ( Figures 4A, 4D , and 4E). There were strong positive correlations between the mRNA expression levels of TGR5, D2, UCP1, PGC-1a, and PRDM16 ( Figure 4A ). Consistent with these observations, we found significantly increased BAT functioning following cold stimulation through positron emission tomographycomputed tomography (PET-CT) ( Figure 4B ) and an increased intrascapular temperature in BE-treated mice ( Figure 4C ), suggesting more powerful NST in the BAT of BE-treated mice. We also found more lamellar cristae in the mitochondria in the BAT of BE-treated mice than in the BAT of vehicle-treated HFD-fed mice ( Figure 4F ). In addition, our results also revealed a significant increase in the key proteins involved in the browning of adipocytes in iWAT, including D2, UCP1, PGC-1a, and PRDM16, although the mRNA expression of TGR5 (p = 0.07) was not significantly influenced by BE administration (Figures 4A and 4E) . Collectively, these results suggested that BE administration promoted NST in BAT and the browning of iWAT through the BA membrane receptor TGR5, thereby increasing the energy expenditure and (in part) contributing to the anti-obesity effect of BE.
BE Improves Obesity and Its Related Metabolic Syndromes in db/db Mice by the Alteration of the GM and BAs
In mouse study 2, male C57BL/KsJ db/db mice purchased at 21 days of age were randomly assigned to two groups (n = 10) as follows: (1) a CHOW2 group fed a chow diet and (2) a BE2 group fed a chow diet with 5 gL -1 BE in drinking water. BE administration decreased genetically induced weight gain with no significant influence on the water consumption, energy intake, and energy in the feces, which was mainly the result of the decreased tissue weight of the liver, iWAT, and eWAT ( Figure 5A ). Liver steatosis, systemic inflammation, fat deposition and glucose metabolism were all improved by BE treatment (Figures 5A, 5C, S2, and S3A). BEtreated mice also had reduced serum TG, cholesterol, and leptin levels compared with mice in the CHOW2 group ( Figure 5A ). The improvement in adiposity was related to increased energy expenditure and an improvement in lipid metabolism ( Figures 5B and S3A ). BE-treated mice showed elevated mRNA expression of genes related to NST in iWAT and BAT and enhanced BAT functioning ( Figures 5B-5E ). There were strong correlations of the mRNA expression levels between TGR5, D2, PGC-1a, and PRDM16 and between FXR, SHP, SREBP-1c and ChREBP, suggesting that the regulation of lipid metabolism and enhancement of NST is closely linked to the activation of BA receptors FXR and TGR5 ( Figures S3A and S3D) .
BE administration increased the diversity of the GM, decreased the abundance of Proteobacteria and the ratio of Firmicutes to Bacteroidetes, and caused a significant difference in the GM of BE-treated mice compared with that of mice in the CHOW2 group, as based on the UniFrac distance ( Figure 5D ). Similar to the results of study 1, BE-treated mice had a lower level of plasma BAs, especially taurine-conjugated primary BAs (mainly TaMCA and TbMCA), and a higher ratio of secondary BAs (mainly LCA and CA) than control mice ( Figure 5E ). We did not observe differences in the fecal BA content or the mRNA expression in the IBAT between the mice in the two groups ( Figure 5E ), which was slightly different from the results of study 1. Moreover, there was a close correlation between the GM and plasma BA pool ( Figure S1D ). In summary, consistent with the results of study 1, BE administration improved genetically induced obesity and its related metabolic syndromes by the activation of TGR5 and FXR via the regulation of the GM and the plasma BA pool.
Antibiotic Treatment Blunts the Improvement in Metabolism by BE
Mouse study 3 was performed to determine whether there was a causal link between the regulation of the GM, the BA pool, and the improvement in metabolism upon BE administration. In this study, adult (8-week-old) mice were used to minimize the side effects of antibiotics on metabolism as distribution of GM through antibiotics during early life time is strongly linked to various disorders such as obesity, type 1 diabetes, and allergy (Cox and Blaser, 2015; Livanos et al., 2016) . Male C57BL/6 mice purchased at 49 days of age were randomly assigned to five groups (n = 10-12) as follows: (1) a CHOW3 group fed a chow diet, (2) an HFD3 group fed an HFD, (3) a BE3 group (5 gL -1 BE in drinking water) fed an HFD, (4) an Abx group fed an HFD, and (5) an ABE group (5 gL -1 BE in drinking water) fed an HFD. All the mice were gavaged daily with 200 mL PBS containing (for the Abx and ABE groups) 0.5 mg mL À1 ampicillin, 0.5 mg mL À1 gentamicin, 0.5 mg mL À1 metronidazole, 0.5 mg mL À1 neomycin, and 0.25 mg mL À1 vancomycin or no antibiotics (for the CHOW3, HFD3, and BE3 groups). Consistently, antibiotics had no significant influence on BW (Figure 6A ), suggesting that the side effect of antibiotics on the BWs of adult mice was negligible. Antibiotics substantially reduced the gut bacteria to undetected levels during the first two weeks, whereas the abundance of fungi was not significantly influenced throughout the experiment ( Figure 6E ). Until the end of the experiment, the bacterial richness in antibiotic-treated mice was still quite low (approximately 10 7 $g À1 feces), despite the increased tolerance to the antibiotics with time ( Figure 6E ). The fecal anthocyanin content was significantly higher in antibiotic-treated mice than in BE-treated antibiotic-free mice (Table S1 ), suggesting the impaired microbial degradation of anthocyanins. We also found that the GM of mice in the Abx and ABE groups was more similar than that of mice in the HFD and BE groups based on the unweighted UniFrac distance ( Figure 6E ). Antibiotic treatment sharply decreased the abundance of total, secondary, and free BAs compared with those in the antibiotic-free mice ( Figure 6F ). There was no significant difference in the plasma BA pool size and composition between mice in the Abx and ABE groups (Figure 6F) . Taken together, these results suggest that antibiotics substantially blocked the interaction between BE and the GM, thereby destroying the regulation of the BA pool through the GM upon BE administration.
The disturbance of the regulation of the BA pool with antibiotic treatment blunted the activation of TGR5 and FXR through BE administration. There were no differences in the mRNA expression levels of FXR and TGR5 and their downstream genes SHP, SREBP-1c, ChREBP, D2, UCP1, PRDM16, and PGC-1a in the antibiotic-and antibiotic-BE-treated HFD-fed mice ( Figure S6 ). Immunohistochemical analysis further showed that antibiotic-BE-treated mice exhibited similar protein expression of TGR5, D2, UCP1, FXR, SHP, and SREBP-1c as that of antibiotic-and vehicle-treated HFD-fed mice ( Figure S7 ). The observations from PET-CT (data not shown), metabolic cage experiments, and transmission electron microscopy were consistent with these observations ( Figure S4 ). Antibiotic-BE-treated mice had BWs, tissue weights, hepatic fat deposition, and serum TG and cholesterol contents similar to those of antibiotic-and vehicle-treated HFD-fed mice (Figures 6A, 6B, and S5 ). The improvement in glucose metabolism upon BE administration was partially but not fully counteracted by antibiotics, which may because of the improved inflammation upon antibiotics treatment ( Figures 6C and 6D) . Collectively, these data suggest that antibiotic treatment damaged the interaction between BE, the GM, and BAs; blunted the activation of TGR5 and FXR; and impaired the metabolic improvement effect of BE.
DCA and LCA Activate the TGR5 Pathway in Mouse Primary Adipocytes Derived from BAT, whereas TaMCA and TbMCA Inhibit the FXR Pathway in Mouse Primary Hepatocytes in a Dose-Dependent Manner
We then sought to determine whether these specific alterations in BAs in vivo could be reproduced in vitro using mouse primary adipocytes and hepatocytes derived from BAT and the liver, respectively. CDCA and LCA (3 mM) enhanced the expression of TGR5, D2, PGC-1a, and UCP1 in mouse primary adipocytes derived from BAT, and higher doses had a more significant influence ( Figures 7C-7F ). We next analyzed the effect of high levels of TaMCA and TbMCA on mouse primary hepatocytes with or without the presence of CDCA and found that CDCA increased the levels of FXR and SHP while suppressing the mRNA and protein expression of SREBP-1c and ChREBP (Figures 7A and 7B) . The supplementation of TaMCA and TbMCA counteracted the effect of CDCA, and higher levels of TaMCA and TbMCA had a stronger effect, suggesting that TaMCA and TbMCA suppressed the activity of FXR and SHP in a dosedependent manner (Figures 7A and 7B) . Collectively, these results showed that the regulation of the plasma BA pool, mainly the reduction in TaMCA and TbMCA and the increase in secondary BAs (such as LCA and CDCA), through BE administration may have had a profound influence on mouse primary cells, which was in agreement with the results observed in vivo and may be responsible for the metabolic improvement effect of BE.
DISCUSSION
We established a possible pathway involving the GM and BAs to describe how the phenolic compounds in blueberries improve diet-and genetically induced adiposity and its related metabolic syndromes. The daily administration of BE strongly ameliorated the obesity-related disturbance of the GM, thereby regulating the abnormal plasma BA pool size and composition, which further activated the membrane and nuclear BA receptors TGR5 and FXR in BAT, iWAT, and the liver. The activation of TGR5 and FXR increased the energy expenditure in BAT, enhanced the browning of iWAT, and improved lipid metabolism in adipose tissues and the liver, therefore reducing adiposity and improving metabolic syndromes.
BE significantly influenced the abundance of various bacterial genera including Akkermansia, Bifidobacterium, Lactobacillus, and Desulfovibrio. Bifidobacterium, and Lactobacillus, which produce BSH, were positively and western blots (B) in mouse primary hepatocytes showed that CDCA enhanced the mRNA and protein expression of FXR and SHP while suppressing that of SREBP-1c and ChREBP, which was counteracted by Ta/bMCA treatment. (C-F) Genes relative mRNA expression (C and E) and western blots (D and F) in mouse primary adipocytes derived from BAT showed that CDCA (C and D) and LCA (E and F) enhanced the mRNA and protein expression of TGR5 and its downstream genes related to thermogenesis; n = 2. For all images, different letters indicate a significant difference between columns, p < 0.05. correlated with the increased concentration of plasma secondary and free BAs, such as CDCA, DCA, and LCA, and the ratio of secondary/primary BAs. A high ratio of secondary to primary BAs is linked to a decreased risk of non-alcoholic steatohepatitis and a healthy liver status (Molinaro et al., 2018) . The high-level expression of BSH in the intestine resulted in reduced weight gain and plasma and hepatic TG concentrations in mice (Joyce et al., 2014) , which is consistent with our observations. Although there was no direct evidence that Akkermansia produced BSH, Akkermansia abundance was correlated with the plasma BA pool, like the abundance of Bifidobacteria and Lactobacillus. The increase in Akkermansia was observed in Roux-en-Y gastric bypass (RYGB) surgery (Cox and Blaser, 2013) , which was also associated with profound alteration of the BA pool (e.g., the reduction of taurine-conjugated BAs), the activation of FXR, significant metabolic improvement, and weight loss in the first week after surgery (Ryan et al., 2014; Li et al., 2011) . Similar to RYGB, BE treatment ameliorated the HFDinduced increase in plasma taurine-conjugated BAs, including TaMCA and TbMCA, which are inhibitors of FXR and usually present in excess in obese individuals (Molinaro et al., 2018; Sayin et al., 2013) , and activated the FXR in the liver. Activation of the FXR in the liver and mouse hepatocytes enhanced the expression of SHP, which further suppressed the activity of SREBP-1c (Watanabe et al., 2004) and its downstream genes related to lipid synthesis including ACC1, AP2, FAS, CD36, and GPAT. The supplementation of CA, an FXR agonist, also lowered TG levels through the activation of the FXR (Watanabe et al., 2004) . BE treatment improved glucose metabolism in both wild-type and db/db mice, which seems to be related to the activation of the FXR in the liver because treatment of db/db mice with the FXR agonist GW4064 decreased hyperglycemia by suppressing the expression of PEPCK and G6Pase . Taken together, these results suggest that the activation of the FXR, whether through the reduction of antagonist (RYGB and BE treatment) or the administration of agonist (CA), improved the metabolism in mice.
CA is also a moderate agonist of TGR5 (Perino and Schoonjans, 2015) , and treating mice with CA prevented diet-induced obesity and IR (Watanabe et al., 2006) . Other kinds of BAs, mainly LCA, DCA, and CDCA, are natural agonists of TGR5 and have effects similar to those of CA (Broeders et al., 2015) . Our results showed that BE administration increased the abundance of these free BAs and that treating mouse primary adipocytes derived from BAT with these BAs activated TGR5 in a dose-dependent manner. The activation of TGR5 induces the intracellular accumulation of cyclic AMP, followed by the downstream activation of its signaling pathways, such as the activation of D2 (Thomas et al., 2008) . D2 converts the prohormone thyroxine (T 4 ) to the active hormone triiodothyronine (T 3 ) and increases metabolic rates (Watanabe et al., 2006) . Consistent with this, the activation of TGR5 enhanced the expression of a series of downstream genes related to energy expenditure of TGR5 including D2, UCP1, PRDM16, and PGC-1a both in vivo and in vitro. Antibiotic treatment dramatically decreased the richness of plasma secondary BAs compared with that in the antibiotic-free mice, and the BAT function of antibiotic-treated mice was also lower. However, this decreased BAT activity did not significantly influence BW, which may be because the extinction of the gut bacteria (that were capable of extracting energy from otherwise digested compounds in food) (Kundu et al., 2017) by antibiotics reduced the energy intake of mice from food, as indicated by the increased energy in the feces of antibiotic-treated mice. More importantly, BE administration had no significant effect on the BA pool and the activity of BAT in antibiotictreated mice, suggesting that gut bacteria played a key role in BE functioning through BAT.
We also found that BE administration significantly reduced the abundance of Desulfovibrio, an important H 2 S-producing bacteria in the intestine . Excess H 2 S can reduce the disulfide bonds in the mucous network and increase the permeability of the intestine, thus contributing to the transposition of bacteria and their metabolites, such as LPS (Ijssennagger et al., 2016) . This transposition is able to trigger an inflammatory response and induce IR . Therefore the reduction in Desulfovibrio may be partially conducive to the improvement of inflammation and glucose metabolism in BE-treated mice.
In summary, BE administration improved metabolism by reducing the FXR antagonist content and increasing the abundance of TGR5 agonists, which was fulfilled through regulation of the GM.
Limitations of the Study
The BE obtained from fresh blueberry fruit was a mixture that consisted of various kinds of phenolic compounds. Therefore, whether there is one or several key ingredients in BE and how BE influences the composition of the GM remains unclear. Moreover, further investigations on GM and BAs are needed to explore the underlying mechanisms of BE-GM-BA-metabolism axis. For example, a full analysis of the BA pools in the plasma, liver, gall bladder, and intestine and the determination of the expressions of BA-related genes would be very helpful to completely understand the influences on BA metabolism by BE treatment.
Similarly, sufficient analysis of GM employing metagenomic and metatranscriptomic approaches is also meaningful to have a comprehensive picture of GM alteration. Nevertheless, these results provide a new perspective on how dietary polyphenols function and show the importance of the interaction between the GM and dietary components. Figure S4 Antibiotics treatment blunted the increase of energy expenditure and the regulation of GM in BE-treated mice, related to Figure 6. (A, B and C) The daily O 2 consumption (A), CO 2 production (B) of mice and the relative AUC (C). Columns indicated with different letters have significant difference, P < 0.05. (D) The daily activity of mice showed that the discrepancy on energy expenditure was not related to the physical activity. BAT (F and H). (B and D) The enhancement of the activation of BAT and the browning of iWAT in BE treated mice were blunted by antibiotics treatment. For all pictures, columns indicated with different letters have significant difference, P < 0.05. Figure 6 . Representative immunohistochemistry images for proteins related to NST in BAT and lipogenesis in liver showed that BE administration enhanced NST and suppressed lipogenesis, which were blunted by antibiotics treatment, n=9-12 The bile acids standards including α-murocholic acid (αMCA), β-murocholic acid (βMCA), tauro-α-murocholic acid (TαMCA), tauro-β-murocholic acid (TβMCA), tauro-ursodesoxycholic acid (TUDCA), taurocholic acid (TCA), tauro-ursodeoxycholic acid (TDCA), glycocholic acid (GCA), glycodeoxycholic acid (GDCA), Cholic acid (CA), ursodeoxycholic acid (UDCA), hyodeoxycholic acid (HDCA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), glycochenodeoxycholic acid (GCDCA), glycoursodeoxycholic acid (GUDCA), taurohyodeoxycholic acid (THDCA), taurolithocholic acid (TLCA), dehydrocholic acid (DHCA), lithocholic acid (LCA), [2,2,4,4-D4] -DCA (DCA-d4), [2,2,4,4-D4] -CA (CA-d4), [2,2,4,4-D4] -CDCA (CDCA-d4), [2,2,4,4-D4] -LCA (LCA-d4), [2,2,4,4-D4] -GCDCA (GCDCA-d4), [2,2,4,4-D4] -GCA (GCA-d4) were all purchased from Steraloids Inc (Newport, Rhode Island, USA).
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Figure S7 Antibiotics treatment blunted the regulation of protein expression related to NST in BAT and lipogenesis in liver, related to
Methods
KEY RESOURCES
CONTACT FOR REAGENT AND RESOURCE SHARING
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
We performed three independent mouse studies to study the effect of BE on adiposity and its related metabolic syndromes based on high fat diet (HFD)-(studies 1 and 3) and genetically-(study 2)-induced obesity models. In study 1, male C57BL/6J mice purchased at 21 days of age (Vital River Laboratory Animal Technology. Co., Ltd., China) were randomly assigned to four groups (n = 9-12) after adapting for one week as follows: (1) a CHOW1 group fed a chow diet (3.85 kcal/g, 10% energy from fat) (D12450B, Research Diets, USA), (2) a HFD1 group fed a HFD (4.73 kcal/g, 60% energy from fat) (D12492, Research Diets), (3) a CBE group (5 gL -1 BE in drinking water) fed a chow diet, and (4) a BE1 group (0.5% (m/v) BE in drinking water) fed a HFD. In study 2, male C57BL/KsJ db/db mice purchased at 21 days of age (Model Animal Research Center of Nanjing University, Nanjing, China) were randomly assigned to two groups (n = 10) as follows: (1) a CHOW2 group fed a chow diet and (2) a BE2 group fed a chow diet with 5 gL -1 BE in drinking water. In study 3, male C57BL/6J mice purchased at 49 days of age (Vital River Laboratory Animal Technology. Co., Ltd.) were randomly assigned to five groups (n = 10-12) as follows: (1) a CHOW3 group fed a chow diet, (2) a HFD3 group fed a HFD, (3) a BE3 group (5 gL -1 BE in drinking water) fed a HFD, (4) an Abx group fed a HFD and (5) an ABE group (5 gL -1 BE in drinking water) fed a HFD. In study 3, all the mice were gavaged daily with 200 μL PBS containing (for the Abx and ABE groups) 0.5 mg ml -1 ampicillin, 0.5 mg ml -1 gentamicin, 0.5 mg ml -1 metronidazole, 0.5 mg ml -1 neomycin and 0.25 mg ml -1 vancomycin 25 (Sigma-Aldrich, USA) or no antibiotics (for the CHOW3, HFD3 and BE3 groups).
Mice in all three studies were housed 3/cage in standard specific pathogen-free (SPF) conditions (12/12 h light/dark cycle, humidity of 50 ± 15%, temperature of 22 ± 2 ℃) and were allowed to adapt for one week before the experiments were started. The food used in these studies was sterilized using radiation (25.0 kGy). Food and water were provided ad libitum, and food intakes were recorded every week. Body weights were recorded weekly, the drinking water was changed every three days and fecal samples were collected at intervals. Mice eighteen weeks of age were fasted for 12 h in all mouse studies, plasma was dried in tubes following eyeball extirpation, and the mice were killed through breaking their necks immediately after taking the blood. After standing for 1 h, the blood was centrifuged at 3000 rpm for 10 min at 4℃ to obtain the blood plasma. The liver, inguinal white adipose tissue (iWAT), epididymal white adipose tissue (eWAT), brown adipose tissue (BAT), skeletal muscle, ileum and colon were obtained, weighed and placed into a 4% aqueous paraformaldehyde solution or liquid nitrogen immediately and then stored at -80℃ or room temperature for further analysis. The contents of the ileum, caecum, colon and rectum were collected and stored at -80℃ for GM analysis.
The guidelines of the National Institutes of Health regarding the care and use of laboratory animals were followed. This study was approved by the Animal Experiment Committee of the College of Food Science and Nutritional Engineering at China Agricultural University.
Cell Separation and Culture
The primary adipocytes were separated from the interscapular BAT of 5-to 6-week-old male mice, and the primary hepatocytes were separated from 8-week-old male mice using collagenase digestion and perfusion methods, respectively. Adipocyte differentiation was induced by treating confluent cells in DMEM (D-glucose, 25 mM) containing 10% fetal bovine serum (FBS), 0.5 mM isobutylmethylxanthine, 125 nM indomethacin, 1 mM dexamethasone, 850 nM insulin, 1 nM T3, 1 lM rosiglitazone, 100 U/ml penicillin, and 100 mg/ml streptomycin. After 2 days of induction, the cells were maintained in differentiation media (10% FBS, 850 nM insulin, 1 nM T3 and 1 lM rosiglitazone) in cell culture plates for the following experiment. 26 Hepatocytes were maintained in DMEM/F-12 (Gibco) with 10% FBS (Gibco), 1% ITS Liquid Media Supplement (Gibco), 40 ng/ml dexamethasone (Sigma), and 1% pen/strep (Gibco) in cell culture plates. All plates were incubated at 37℃ in 5% CO 2 .
Adipocytes were treated with different concentrations (3 μM, 30 μM or 300 μM) of CDCA or LCA for 24 h, and then the cells were collected for mRNA expression and western blotting analysis. Hepatocytes were treated with or without CDCA (50 μM) and different concentrations (0, 100 μM or 300 μM) of TαMCA and TβMCA for 12 h for mRNA expression analysis and 24 h for western blotting analysis.
METHOD AND DETAILS
Extract and Analysis of the Phenolic Compounds in BE and Feces
The blueberries used in this study were highbush blueberries (Vaccinium corymbosum) grown in the Daxing District, Beijing, China and harvested in 2016. The extraction and analysis of phenolic compounds from blueberries were performed as previously described with some modification. 27 Briefly, blueberry fruit or fresh feces was macerated and stirred with 95% ethanol (1:5, w (g)/v (ml)). The extract was then purified through an Amberlite XAD-7 column. The phenolic compounds were eluted with moderate absolute ethanol with 1% (v/v) formic acid. The eluent was concentrated under reduced pressure at 35°C and freeze-dried.
The total polyphenol content in the BE was determined with a modified Folin-Ciocalteu method, and the total anthocyanin content of the BE was directly determined using a pH differential method as previously described. 27 The results are presented as mg gallic acid or cyanidin-3-O-glucoside equivalent/100 mg of BE, respectively.
The concentrations of phenolic compounds in the BE and anthocyanins in the feces were determined with a UPLC (Waters, Milford, MA, USA) equipped with a QqQ-MS and diode array detector (DAD) as described with some modifications. 28 Chromatographic separations were performed on an Acquity UPLC HSS T3 (Waters) column (2.1× 100 mm, 1.7 μm). The injection volume was 2 μL, and a 0.4 mL/min flow rate was used. The mobile phase consisted of 2 phases: (A) and (B). Mobile phase (A) was 5% (v/v) formic acid in water, and mobile phase (B) was 5% (v/v) formic acid in acetonitrile. BE and FE were dissolved in mobile phase (A) and filtered through a 0.22 μm membrane filter. The elution conditions were as follows: 0~0.5 min, 99% A; 0.5~16 min, 99~65% A; 16~18 min, 65~0% A; 18~21 min, 0% A; 21~23 min, 0~99% A; 23~23.5 min, 99% A. The column temperature was 40°C, and the detection wavelength was 520 nm (for the determination of anthocyanins).
Determination of the Composition and Concentration of Bile Acids in the Plasma
through LC-MS
The plasma composition and concentration of twenty common bile acids were determined through UPLC/electrospray ionization mass spectrometry (UPLC/ESI-MS) as described with some modification. 29 Briefly, one milliliter of precooled ethanol was added to a 50 μL plasma sample. Following vortex and centrifugation, the supernatant was then filtered with a 0.22 μm filter before analysis with LC-MS.
Liquid chromatography (LC) separation was performed using a Waters Acquity UPLC system with a BEH C18 column (1.7 μm, 100 mm, 2.1 mm; Waters) and maintained at 40°C. The sample injection volume was 1 μL. Solvent A was water containing 0.005% (v/v) formic acid. Solvent B was acetonitrile containing 0.005% formic acid, and the flow rate was 0.4 mL/min. The gradient program was as follows: 0 ~ 2 min, 77% ~ 67% A; 2 ~ 6 min, 67% ~ 66% A; 6 ~ 11 min, 66% ~ 30% A. MS analysis was performed using a Quattro Premier XE quadrupole tandem MS (Waters) equipped with an ESI probe in negative-ion mode. A capillary voltage of -3,200 V, a source temperature of 120°C, and a desolvation temperature of 400°C were used. The concentrations of individual BAs were calculated from the peak area in the chromatogram detected with selected ion recording relative to that of the internal standard, nordeoxycholic acid.
Quantitative Real-time PCR (qPCR) Analysis
Total RNA was extracted using TRIzol TM reagent (Invitrogen) according to the manufacturer's instructions. Reverse transcription of the total RNA (2.5 μg) was performed with a high-capacity cDNA reverse transcription kit (Promega Biotech Co., Ltd). qPCR was run in triplicate for each sample and analyzed in a LightCycler 480 real-time PCR system (Roche). Data were normalized to the internal control β-actin and analyzed using the △△CT method. 30 The expression of genes related to lipid metabolism (in the WAT, BAT and liver), inflammation (in the WAT and liver), permeability (in the ileum and colon), and thermogenesis (in the BAT), as well as the bacterial load, were determined through qPCR (the related genes and primers used are shown in Table S1 ). Quantification of the bacterial load through qPCR was conducted as previously described. 30 Briefly, the total bacterial DNA was isolated from the samples with a QIAamp DNA Stool Mini Kit (Qiagen). The DNA was then subjected to qPCR using a QuantiFast SYBR Green PCR kit (Bio-Rad) with universal 16S rRNA primers (Table 1 ). 2 The results are expressed as bacterial number per g of sample using a standard curve made using Bifidobacterium longum.
Metabolic Rate and Physical Activity
Oxygen consumption and physical activity were determined in 16-week-old mice before a GTT. Oxygen consumption was measured using TSE lab master systems as previously described. 22 All mice were acclimatized for 24 h prior to the measurements, and then VO 2 and VCO 2 were measured over the course of 24 h. The mice were maintained at 25°C under a 12 h light/dark cycle with free access to food and water. Their physical activity was measured by the optical beam technique (Opto-M3; Columbus Instruments, Columbus, OH, USA) over 24 h and calculated as 24 h average activity.
Positron Emission Tomography-Computed Tomography and Transmission
Electron Microscopy
At the end of the experiment, the mice fasted overnight. After exposure to a cold environment (4°C) for 30 min, the mice were lightly anesthetized with isoflurane and injected with 18F-FDG (500 mCi) via the tail vein. Sixty minutes after radiotracer injection, the mice were subjected to PET/CT imaging with the Siemens Inveon Dedicated PET (dPET) system and an Inveon Multimodality System (CT/SPECT) (Siemens Preclinical Solutions, Knoxville, TN, USA) at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Inveon Acquisition Workplace software was used for the scanning process. The positron emission tomography-computed tomography (PET-CT) instrument parameters were as previously described, and data analysis was performed as previously described. 31 BAT sections were fixed with 2% (v/v) glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 12 h at 4°C. The sections were then postfixed with 1% osmium tetroxide, dehydrated in ascending concentrations of ethanol, and embedded in fresh epoxy resin 618. Ultrathin sections (60-80 nm) were cut and stained with lead citrate before being examined on a Hitachi H-7500 transmission electron microscope.
